Catalyst Capital Advisors’s Precigen PGEN Stock Holding History

Catalyst Capital Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,036	Closed	-$136K	–	511
2016 Q1	$136K	Hold	4,036	–	–	0.02%	274
2015 Q4	$121K	Hold	4,036	–	–	0.02%	311
2015 Q3	$127K	Sell	4,036 -5,550	-58%	-$271K	0.02%	307
2015 Q2	$464K	Sell	9,586 -3,493	-27%	-$147K	0.05%	240
2015 Q1	$567K	Buy	+13,079	New	+$470K	0.07%	193
2014 Q3	–	Sell	-143,871	Closed	-$3.46M	–	467
2014 Q2	$3.46M	Buy	+143,871	New	+$2.92M	0.56%	73
2014 Q1	–	Sell	-26,158	Closed	-$595K	–	343
2013 Q4	$595K	Buy	+26,158	New	+$529K	0.19%	156

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Catalyst Capital Advisors's PGEN Position: Q2 2016 in Review

Catalyst Capital Advisors sold out of Precigen (PGEN) in Q2 2016, closing a stake of 4,036 shares — an estimated $136K sold.

Catalyst Capital Advisors first reported a position in PGEN in Q4 2013 and held it in 7 quarters. The position peaked at $3.46M in Q2 2014. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

Catalyst Capital Advisors reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
Catalyst Capital Advisors sold 4,036 Precigen shares in Q2 2016, an estimated $136K.
Catalyst Capital Advisors first reported a position in Precigen in Q4 2013 and held it in 7 quarters.
Catalyst Capital Advisors's Precigen position peaked at $3.46M in Q2 2014.
169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Catalyst Capital Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.